300 related articles for article (PubMed ID: 1979304)
1. Tardive dyskinesia: managing a common neuroleptic side effect.
Jeste DV; Krull AJ; Kilbourn K
Geriatrics; 1990 Dec; 45(12):49-54. PubMed ID: 1979304
[TBL] [Abstract][Full Text] [Related]
2. Prevention and management of tardive dyskinesia.
Jeste DV; Wyatt RJ
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):14-8. PubMed ID: 2858473
[TBL] [Abstract][Full Text] [Related]
3. Comparison of severe and mild tardive dyskinesia: implications for etiology.
Gardos G; Cole JO; Schniebolk S; Salomon M
J Clin Psychiatry; 1987 Sep; 48(9):359-62. PubMed ID: 2887550
[TBL] [Abstract][Full Text] [Related]
4. Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications.
Glazer WM; Morgenstern H; Doucette JT
J Clin Psychiatry; 1993 Apr; 54(4):133-9. PubMed ID: 8098030
[TBL] [Abstract][Full Text] [Related]
5. Preventing neuroleptic-induced tardive dyskinesia in adults and children.
Lam RW; Jeste SD; Jeste DV
Encephale; 1988 Sep; 14 Spec No():251-5. PubMed ID: 2905652
[TBL] [Abstract][Full Text] [Related]
6. Clinical and epidemiologic aspects of tardive dyskinesia.
Baldessarini RJ
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):8-13. PubMed ID: 2858483
[TBL] [Abstract][Full Text] [Related]
7. Tardive dyskinesia: a review and current treatment options.
Najib J
Am J Ther; 1999 Jan; 6(1):51-60. PubMed ID: 10423647
[TBL] [Abstract][Full Text] [Related]
8. Organic brain dysfunction and cognitive deficits in young schizophrenic patients with tardive dyskinesia.
Pourcher E; Cohen H; Cohen D; Baruch P; Bouchard RH
Brain Cogn; 1993 Sep; 23(1):81-7. PubMed ID: 8105825
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for tardive dyskinesia according to primary psychiatric diagnosis.
Wolf ME; DeWolfe AS; Mosnaim AD
Hillside J Clin Psychiatry; 1987; 9(1):3-11. PubMed ID: 2888712
[TBL] [Abstract][Full Text] [Related]
10. Relationship between neuroleptic extrapyramidal syndromes and patients' all-cause mortality.
Modestin J; Vogt Wehrli M; Stephan PL; Agarwalla P
Pharmacopsychiatry; 2009 Mar; 42(2):57-60. PubMed ID: 19308879
[TBL] [Abstract][Full Text] [Related]
11. [Neuroleptic-induced movement disorders: historical perspectives].
Wolf MA; Yassa R; Llorca PM
Encephale; 1993; 19(6):657-61. PubMed ID: 12404786
[TBL] [Abstract][Full Text] [Related]
12. Movement disorders associated with neuroleptic treatment.
Wirshing WC
J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of tardive dyskinesia.
Tepper SJ; Haas JF
J Clin Psychiatry; 1979 Dec; 40(12):508-16. PubMed ID: 40964
[TBL] [Abstract][Full Text] [Related]
14. [Tardive dyskinesia: a review].
Crespo Facorro B; Payá González B; Ruiz Fernández V; Carbonell Masia C
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1997; 25(2):118-27. PubMed ID: 9245189
[TBL] [Abstract][Full Text] [Related]
15. Factors in the development of severe forms of tardive dyskinesia.
Yassa R; Nair NP; Iskander H; Schwartz G
Am J Psychiatry; 1990 Sep; 147(9):1156-63. PubMed ID: 1974745
[TBL] [Abstract][Full Text] [Related]
16. Diabetes is not a risk factor for tardive dyskinesia: a retrospective observational study.
Raja M; Azzoni A
Hum Psychopharmacol; 2002 Jan; 17(1):61-3. PubMed ID: 12404708
[TBL] [Abstract][Full Text] [Related]
17. A summary of current knowledge of tardive dyskinesia.
Baldessarini RJ
Encephale; 1988 Sep; 14 Spec No():263-8. PubMed ID: 2905654
[TBL] [Abstract][Full Text] [Related]
18. [Tardive dyskinesia. A possible complication of chronic treatment with neuroleptics].
D'Aquila F; Rampello L
Riv Neurol; 1990; 60(4):140-5. PubMed ID: 1982720
[TBL] [Abstract][Full Text] [Related]
19. Focus on lower risk of tardive dyskinesia with atypical antipsychotics.
Nasrallah HA
Ann Clin Psychiatry; 2006; 18(1):57-62. PubMed ID: 16517454
[TBL] [Abstract][Full Text] [Related]
20. Tardive dyskinesia in outpatients on depot phenothiazine.
Neehall J
West Indian Med J; 1989 Dec; 38(4):228-33. PubMed ID: 2576166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
